| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 7,140 | 14,490 | 13,720 | 11,290 | 9,710 |
| Sales Growth | -50.72% | +5.61% | +21.52% | +16.27% | +8.61% |
| Net Income | -3,490 | 3,380 | 2,270 | 1,390 | -850 |
| Net Income Growth | -203.25% | +48.90% | +63.31% | +263.53% | -254.17% |
Ceapro Inc (CRPOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Ceapro Inc. is a biotechnology company. The company develop and commercialize ingredients for human and animal health markets. Its product pipeline includes botanical product & oat product. The company's technology consists of PGX Technology. Ceapro Inc. is headquartered in Edmonton, Canada.
Fiscal Year End Date: 12/31